Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: Michael Olin who wrote (653)	10/30/1998 6:21:00 AM
From: Cage Rattler	Read Replies (1) \| Respond to of 1255

Mike: No argument on the risk aspects of small biotechs -- always a crap shoot as you say. Sorry but I just don't think the whims of casual traders moved 25% of the outstanding shares in a few days at about 1/2 of the previous weeks price. I also don't buy the CFO leaving unexpectedly as a career advancing move. <Positive overall trend> -- check out the winners like ENMD. Overall, long term upward slope after their initial settling-down. Without arguing the semantics of "worth," let me say that no stock is worth more than you can sell/buy it for in real time. Potential? Of course. The only meaningful question, beyond the tax issue, is buy/sell/hold based upon the current price and information, period. If you enjoy inside information for example, then your decision is easy. I think it is a common intellectual error to make current investment decisions based upon emotional attachment to outdated price and circumstance. The question now, do you buy, sell, or hold CORX based upon today's price and the information available today? Ciao, Ted